Sign In
Buy RBGLY
$14.05
-0.300 (-2.09%)
At Close: Jul 31, 2026
Reckitt restructuring will see 30% of business divested - analyst
07:36am, Wednesday, 24'th Jul 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB)'s dramatic upheaval plans will result in the divestment of approximately 30% of its business, according to analysis from UBC. Announced alongside an inte
Job cuts expected as Reckitt declares major business shake-up
03:01am, Wednesday, 24'th Jul 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), the FMCG giant responsible for the majority of the average Brit's cleaning cupboard, has declared a sweeping reorganisation of its business that will se
Reckitt Benckiser needs to draw line under infant formula litigation, says Barclays
08:54am, Monday, 22'nd Jul 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) half-year update on Wednesday (24 July) will see infant formula litigation remain the dominant factor, analysts at Barclays believe. One of the investme
Household goods giant Reckitt sustained ‘significant damage' from Indiana tornado strike
02:37am, Wednesday, 17'th Jul 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), the FMCG giant behind Dettol, Durex, Finish and Gaviscon, sustained “significant damage” to its warehouse in the US state of Indiana during a tornad
Reckitt Benckiser numbers tweaked down by leading investment bank - here's why
09:55am, Monday, 10'th Jun 2024
Barclays has issued a research note forecasting slower growth for Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) due to continued destocking of cold and flu products and a sluggish recovery in infant
Reckitt Benckiser: Attractive Price For Its Stable Of Brands (Rating Upgrade)
12:42am, Wednesday, 05'th Jun 2024
Reckitt, a consumer goods producer, has experienced a decline in share price due to concerns over its nutrition business and ongoing legal issues. Despite underwhelming business performance, Reckitt's
Reckitt faces activist investor as baby formula crisis looms
08:55am, Wednesday, 22'nd May 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), the consumer goods giant, could have an activist investor to worry about, adding yet another worry for management as its shares continue to slip. Eminen
Reckitt Benckiser's update represents strong showing, says investment bank
10:22am, Thursday, 25'th Apr 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) reported a robust first quarter, signalling significant operational improvements under its new leadership, according to research by UBS. This comes after
Reckitt delivered an ‘impressive' sales beat, says Barclays
09:51am, Wednesday, 24'th Apr 2024
Dettol, Durex and other living essentials provider Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) flew to the top of the FTSE 100 risers list on Wednesday despite delivering a 4.5% fall in statutory r
Dettol-maker Reckitt revenues lower, price-led growth simmers down
02:51am, Wednesday, 24'th Apr 2024
FTSE 100 consumer goods group Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB)'s revenues fell 4.6% year on year in the first quarter, though this was broadly in line with expectations. Hygiene comprisi
Reckitt beats quarterly like-for-like sales estimates
02:19am, Wednesday, 24'th Apr 2024
Consumer goods group Reckitt's like-for-like sales growth beat estimates in the first quarter as more people bought its Lysol, Dettol and Finish cleaning products even as prices rose, it said in a tra
Reckitt Benckiser: American bank upgrades, but remains cautious; here's why
06:43am, Tuesday, 23'rd Apr 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has been upgraded to 'hold' from 'underperform' by Jefferies, bumping its valuation up by £3 a share to £44. In a note entitled Time To Use The Slack T
Could Reckitt spin out baby formula wing following Enfamil crisis?
10:46am, Tuesday, 19'th Mar 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB)'s shares continue to suffer amid a series of legal challenges related to its baby formula products. The company is facing litigation and significant fin
Reckitt Benckiser sees modest bounce following $7.1 billion market-cap wipeout
10:53am, Monday, 18'th Mar 2024
Reckitt Benckiser saw modest gains on Monday, following the share-price slide that erased some £5.6 billion ($7.1 billion) of market value.
Enfamil maker vows to fight $60 million baby-formula verdict
03:02pm, Friday, 15'th Mar 2024
Reckitt Beckinser Group said Friday it will seek to overturn a court ruling this week that awarded $60 million in damages to the family of a baby that died after being fed Enfamil infant formula, made
